Related Experiment Video
Updated: Jun 13, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
Notch signaling is not essential in sonic hedgehog-activated medulloblastoma
B A Hatton1, E H Villavicencio, J Pritchard
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Abstract:
Dysregulated signal transduction through the notch pathway has been noted in human and mouse medulloblastoma studies. Gamma secretase inhibitors (GSIs) impair notch signaling by preventing the cleavage of transmembrane notch proteins into their active intracellular domain fragments. Previous studies have shown that GSI treatment caused apoptosis and impaired medulloblastoma cell engraftment in xenograft systems. In this study, we used in vivo genetic and pharmacologic approaches to quantify the contribution of notch signaling to sonic hedgehog (shh)-activated mouse medulloblastoma models. In contrast to prior in vitro studies, pharmacologic inhibition of notch pathways did not reduce the efficiency of medulloblastoma xenotransplantation nor did systemic therapy impact tumor size, proliferation, or apoptosis in genetically engineered mouse medulloblastoma models. The incidence and pathology of medulloblastomas driven by the SmoA1 transgene was unchanged by the bi-allelic absence of Notch1, Notch2, or Hes5 genes. These data show that notch signaling is not essential for the initiation, engraftment, or maintenance of sonic hedgehog pathway-driven medulloblastomas.
Insights
Notch signaling is not essential for sonic hedgehog (shh)-activated medulloblastoma initiation or growth. Gamma secretase inhibitors did not impact tumor progression in mouse models, challenging previous findings.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Dysregulated Notch signaling is implicated in human and mouse medulloblastoma.
- Gamma secretase inhibitors (GSIs) block Notch signaling by inhibiting protein cleavage.
- Prior in vitro studies suggested GSIs impair medulloblastoma cell engraftment.
Purpose of the Study:
- To quantify Notch signaling's contribution to sonic hedgehog (shh)-activated mouse medulloblastoma.
- To investigate the role of Notch pathway in medulloblastoma initiation, engraftment, and maintenance.
Main Methods:
- Utilized in vivo genetic and pharmacologic approaches in mouse models.
- Administered GSIs to pharmacologically inhibit Notch pathways.
- Generated genetically engineered mouse medulloblastoma models with bi-allelic absence of Notch1, Notch2, or Hes5 genes.
Main Results:
- Pharmacologic Notch inhibition did not reduce medulloblastoma xenotransplantation efficiency.
- Systemic therapy did not impact tumor size, proliferation, or apoptosis in mouse models.
- Absence of Notch1, Notch2, or Hes5 genes did not alter medulloblastoma incidence or pathology in SmoA1-driven models.
Conclusions:
- Notch signaling is not essential for the initiation, engraftment, or maintenance of shh-driven medulloblastomas.
- Findings contrast with previous in vitro studies, highlighting the importance of in vivo validation.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Regulation of Angiogenesis and Blood Supply

